FDA sees ‘appropriate’ transition period for COVID-19 test EUAs when public health emergency ends

FDA is planning to give holders of EUAs for COVID-19 diagnostics and other devices 180 days notice of its intent to terminate their authorizations, in anticipation of U.S. public health emergency declarations no longer being in effect.